Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine ...
Jun 14, 2021
0
1
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or ...
Jun 02, 2021
0
6
Patients with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes shortness of breath and low oxygen levels because of lung scarring, have worse outcomes if they live in poor neighborhoods, according to research ...
May 16, 2021
0
2
The triggers and causes of a severe scarring disease of the lungs—idiopathic pulmonary fibrosis, or IPF—remain unclear.
Mar 18, 2021
0
102
Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF). The study, which will ...
Mar 10, 2021
0
3
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
Dec 08, 2020
0
10
A multi-channel recording device developed at TU Graz for pathological lung sounds and associated automatic lung sound analysis could support existing screening methods for early detection of, for example, COVID-19 infections. ...
Dec 07, 2020
0
0
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.
Nov 11, 2020
0
3
Autoimmune disease is fundamentally a mystery: whyever should an organism systematically set out to harm itself? Now, researchers at the University of Tsukuba have identified a genetic basis for anti-neutrophil cytoplasmic ...
Nov 04, 2020
0
2
Your lungs and airways need to be stretchy, sort of like balloons. Take a big breath, and they'll open right up.
Sep 24, 2020
0
28
Idiopathic pulmonary fibrosis (IPF) (or cryptogenic fibrosing alveolitis (CFA) / or Idiopathic Fibrosing Interstitial Pneumonia) is a chronic, progressive form of lung disease characterized by fibrosis of the supporting framework (interstitium) of the lungs. By definition, the term is used only when the cause of the pulmonary fibrosis is unknown ("idiopathic").
Microscopically, lung tissue from patients shows a characteristic set of histologic/pathologic features known as usual interstitial pneumonia (UIP). UIP is therefore the pathologic counterpart of IPF.
This text uses material from Wikipedia licensed under CC BY-SA
